Clovis Oncology Inc (NASDAQ:CLVS)

12.96
Delayed Data
As of Jul 15
 -0.29 / -2.19%
Today’s Change
11.50
Today|||52-Week Range
48.40
-27.84%
Year-to-Date

Today’s Trading

Previous close13.25
Today’s open13.32
Day’s range12.88 - 13.53
Volume1,226,503
Average volume (3 months)1,594,656
Market cap$702.8M
Data as of 4:00pm ET, 07/15/2019

Growth & Valuation

Earnings growth (last year)+3.97%
Earnings growth (this year)+3.71%
Earnings growth (next 5 years)+36.29%
Revenue growth (last year)+71.84%
P/E ratioNM
Price/Sales9.80
Price/Book4.78

Competitors

 Today’s
change
Today’s
% change
ZEALZealand Pharma A/S-0.24-1.08%
CLLSCellectis SA-0.45-2.78%
MNKMallinckrodt Plc-0.17-1.98%
VNDAVanda Pharmaceutical...-0.09-0.66%
Data as of 4:15pm ET, 07/15/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$95.4M
Annual profit (last year)-$368.0M
Net profit margin-385.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts